vimarsana.com

Page 245 - ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

花旗:給予貝康醫療(2170 HK)「買入」評級,目標價40港元

花旗:給予貝康醫療(2170 HK)「買入」評級,目標價40港元
sina.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.tw Daily Mail and Mail on Sunday newspapers.

Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe

Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe - Environmental, Social and Governance (ESG) goals focus on key topics including access and affordability, diversity and inclusion, racial justice and the environment - New ESG portal, esg.lilly.com, launched today as a comprehensive source for Lilly sustainability information News provided by Share this article Share this article INDIANAPOLIS, May 4, 2021 /PRNewswire/  Eli Lilly and Company (NYSE: LLY) will outline its newly updated Environmental, Social and Governance (ESG) strategy, highlighting its commitments in key areas during the company s Sustainability Webcast today at 10:30 am ET. In addition, Lilly has launched a new comprehensive resource to provide transparency around the company s ESG goals and progress at esg.lilly.com.

CW Petroleum Corp (CWPE): Reports 60% Increase in Product

Lilly accelerating baricitinib s availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements

Share this article Share this article INDIANAPOLIS, May 4, 2021 /PRNewswire/ Eli Lilly and Company (NYSE: LLY) announces new initiatives to help COVID-19 patients in India as part of its commitment to bring the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world. Lilly is offering donations of baricitinib to the Indian government through Direct Relief while simultaneously working with local Indian pharmaceutical companies to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic. An initial donation of 400,000 baricitinib tablets is being made immediately available to the Indian government for eligible hospitalized COVID-19 patients in India and Lilly will work urgently to increase the quantity of donated product multifold over the coming weeks.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.